David M. Ashley

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Amar Gajjar, Murali Chintagumpala, David M. Ashley et al. · The Lancet Oncology · 2006 · 949 citations · Full text

Medicine, Oncology, Pediatrics +17

Recurrent Glioblastoma Treated with Recombinant Poliovirus

Annick Desjardins, Matthias Gromeier, James E. Herndon et al. · New England Journal of Medicine · 2018 · 802 citations · Full text

Pharmacy, Infectious Diseases, Oncology +17

Genomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations

Margaret C. Thompson, Christine Fuller, Twala L. Hogg et al. · Journal of Clinical Oncology · 2006 · 671 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14

Glioma progression is shaped by genetic evolution and microenvironment interactions

Frederick S. Varn, Kevin C. Johnson, Jason T. Huse et al. · Cell · 2022 · 498 citations · Full text

Medicine, Cancer Biology, Oncology +16

Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors

David M. Ashley, Brenda Faiola, Smita K. Nair et al. · The Journal of Experimental Medicine · 1997 · 448 citations · Full text

Medicine, Immunology, Oncology +17